← Back to guidelines
Cardiology4 papers

Moderate aortic valve regurgitation

Last edited: 4/10/2026

Overview

Moderate aortic regurgitation (AR) is a condition characterized by backward flow of blood from the aorta into the left ventricle during diastole, with a moderate degree of severity. This can lead to volume overload of the left ventricle and potential adverse cardiac remodeling.

Diagnosis

  • Aortic regurgitant volume and regurgitant fraction measured by cardiovascular MRI are associated with a higher incidence of adverse events in patients with moderate-to-severe AR 1.
  • Adverse left ventricular remodeling, indicated by increased end-diastolic or end-systolic volume on cardiovascular MRI, is also associated with adverse events 1.
  • Management

  • Cardiovascular MRI parameters, such as aortic regurgitant volume and regurgitant fraction, can help prognosticate patients with moderate-to-severe AR 1.
  • Adverse remodeling on cardiovascular MRI is a prognostic indicator for adverse events in moderate-to-severe AR 1.
  • Key Recommendations

  • Cardiovascular MRI parameters including aortic regurgitant volume and regurgitant fraction are associated with increased risk of adverse events in patients with moderate-to-severe AR 1. (Evidence: Moderate)
  • Adverse left ventricular remodeling, as assessed by increased end-diastolic or end-systolic volume on cardiovascular MRI, is associated with increased risk of adverse events in patients with moderate-to-severe AR 1. (Evidence: Moderate)
  • References

    1 Figliozzi S, Stankowski K, Di Maio S, Pateras K, Rojanathagoon T, Marchenko O et al.. Prognostic Value of Cardiovascular MRI in Asymptomatic Patients with Moderate-to-Severe Aortic Regurgitation: A Network Meta-Analysis. Radiology. Cardiothoracic imaging 2025. link

    Original source

    1. [1]
      Prognostic Value of Cardiovascular MRI in Asymptomatic Patients with Moderate-to-Severe Aortic Regurgitation: A Network Meta-Analysis.Figliozzi S, Stankowski K, Di Maio S, Pateras K, Rojanathagoon T, Marchenko O et al. Radiology. Cardiothoracic imaging (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG